New Delhi: Serum Institute of India (SII) on Thursday said it is pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate in the country. Earlier this week, AstraZeneca said it had paused the trials because of ‘an unexplained illness’ in a participant in the study. However, SII on Wednesday said it was continuing with the […]
Read MoreNew Delhi: India is considering Russia’s request for conducting phase-3 clinical trial and manufacturing of its COVID-19 vaccine Sputnik V by Indian firms, officials said Tuesday, noting there has been “significant movement” on both these fronts and specific outcomes are expected soon. Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert […]
Read MoreMoscow: The mayor of Moscow invited residents Wednesday to join trials of a coronavirus vaccine that Russia approved for use earlier this month in what officials described as a breakthrough on par with the Soviet Union’s launch of the world’s first satellite in 1957. The world’s first vaccine against the coronavirus to receive a government go-ahead has caused unease […]
Read MoreLondon: Pharma giant AstraZeneca struck a deal Saturday with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental COVID-19 vaccine, as efforts to boost manufacturing capacity continue at pace. The alliance, which was forged by Germany, France, Italy and the Netherlands to speed up production of a vaccine, is set […]
Read MoreParis: France’s president is taking on the role of salesman in chief for his strike-battered country. Emmanuel Macron used the splendor of the Palace of Versailles to woo international business leaders on Monday, insisting that his reforms are attracting investors despite six weeks of crippling protests and walkouts over his plan to overhaul the retirement […]
Read More